drugset / Trial / NCT03633604
Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia
Summary
HBOC-201 provides an oxygen treatment bridge and can be used to eliminate, delay, or reduce the need for red blood cell transfusions in anemic patients This is an expanded access IND protocol, and will provide treatment with HBOC-201 to severely anemic adults for whom blood is not an option
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HBOC-201 | Protein / enzyme biologic | — | Intravenous |